https://www.selleckchem.com/products/A-966492.html
035) and TNBC (P=0.001). Moreover, increased levels of TILs (either iTILs or sTILs) were associated with survival benefit in HER2-positive breast cancer and TNBC. However, an increased level of TILs was not a prognostic factor for survival in HR positive breast cancer (pooled HR=0.64, 95%CI 0.03-14.1, P=0.78). Increased levels of TILs were associated with increased rates of response to NACT and improved prognosis for the molecular subtypes of TNBC and HER2-positive breast cancer, but not for patients with HR positive breast cancer. A t
Curtir
Comentario
Compartilhar
